Home  /  Resource Library  /  CAR T Cells Shown Effective Without Increased Risk of CRS or ICANS in CNS Involved LBCL

CAR T Cells Shown Effective Without Increased Risk of CRS or ICANS in CNS Involved LBCL

Transplantation and Cellular Therapy 2022: Study examined CAR-T therapies for treatment of central nervous system involved large cell lymphomas.